Drug Type Small molecule drug |
Synonyms Mometasone/nortriptyline, Nortriptyline/mometasone |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists), MAO inhibitors(Monoamine oxidase inhibitors) |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H30Cl2O6 |
InChIKeyWOFMFGQZHJDGCX-ZULDAHANSA-N |
CAS Registry83919-23-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atrophy | Phase 2 | DE | 01 Sep 2007 | |
Psoriasis | Phase 2 | DE | - |